These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 9370187)
21. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Yamaguchi T; Pelling JC; Ramaswamy NT; Eppler JW; Wallace DP; Nagao S; Rome LA; Sullivan LP; Grantham JJ Kidney Int; 2000 Apr; 57(4):1460-71. PubMed ID: 10760082 [TBL] [Abstract][Full Text] [Related]
22. Sodium pump distribution is not reversed in the DBA/2FG-pcy, polycystic kidney disease model mouse. Kawa G; Nagao S; Yamamoto A; Omori K; Komatz Y; Takahashi H; Tashiro Y J Am Soc Nephrol; 1994 Jun; 4(12):2040-9. PubMed ID: 7919157 [TBL] [Abstract][Full Text] [Related]
23. Renal anemia in polycystic kidney disease mouse. Masunaga H; Hirabayashi M; Takahira R; Imai E; Kawanishi G J Vet Med Sci; 1991 Aug; 53(4):621-7. PubMed ID: 1834204 [TBL] [Abstract][Full Text] [Related]
24. Renal cyclooxygenase products are higher and lipoxygenase products are lower in early disease in the pcy mouse model of adolescent nephronophthisis. Yamaguchi T; Lysecki C; Reid A; Nagao S; Aukema HM Lipids; 2014 Jan; 49(1):39-47. PubMed ID: 24178445 [TBL] [Abstract][Full Text] [Related]
25. Glycogen synthase kinase-3β promotes cyst expansion in polycystic kidney disease. Tao S; Kakade VR; Woodgett JR; Pandey P; Suderman ED; Rajagopal M; Rao R Kidney Int; 2015 Jun; 87(6):1164-75. PubMed ID: 25629553 [TBL] [Abstract][Full Text] [Related]
26. Exploring urinary biomarkers in autosomal dominant polycystic kidney disease. Kawano H; Muto S; Ohmoto Y; Iwata F; Fujiki H; Mori T; Yan L; Horie S Clin Exp Nephrol; 2015 Oct; 19(5):968-73. PubMed ID: 25543187 [TBL] [Abstract][Full Text] [Related]
28. Caffeine Accelerates Cystic Kidney Disease in a Pkd1-Deficient Mouse Model. Meca R; Balbo BE; Ormanji MS; Fonseca JM; Iannuzzi LR; Santana Costa E; Onuchic LF; Heilberg IP Cell Physiol Biochem; 2019; 52(5):1061-1074. PubMed ID: 30977988 [TBL] [Abstract][Full Text] [Related]
29. Evidence for a potent lipid secretagogue in the cyst fluids of patients with autosomal dominant polycystic kidney disease. Grantham JJ; Ye M; Davidow C; Holub B; Sharma M J Am Soc Nephrol; 1995 Oct; 6(4):1242-9. PubMed ID: 8589292 [TBL] [Abstract][Full Text] [Related]
30. A hereditary model of slowly progressive polycystic kidney disease in the mouse. Takahashi H; Calvet JP; Dittemore-Hoover D; Yoshida K; Grantham JJ; Gattone VH J Am Soc Nephrol; 1991 Jan; 1(7):980-9. PubMed ID: 1883968 [TBL] [Abstract][Full Text] [Related]
31. TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling. Masyuk TV; Masyuk AI; Lorenzo Pisarello M; Howard BN; Huang BQ; Lee PY; Fung X; Sergienko E; Ardecky RJ; Chung TDY; Pinkerton AB; LaRusso NF Hepatology; 2017 Oct; 66(4):1197-1218. PubMed ID: 28543567 [TBL] [Abstract][Full Text] [Related]
32. Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease. Raman A; Parnell SC; Zhang Y; Reif GA; Dai Y; Khanna A; Daniel E; White C; Vivian JL; Wallace DP Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1695-F1707. PubMed ID: 30332313 [TBL] [Abstract][Full Text] [Related]
35. Tolvaptan delays the onset of end-stage renal disease in a polycystic kidney disease model by suppressing increases in kidney volume and renal injury. Aihara M; Fujiki H; Mizuguchi H; Hattori K; Ohmoto K; Ishikawa M; Nagano K; Yamamura Y J Pharmacol Exp Ther; 2014 May; 349(2):258-67. PubMed ID: 24570071 [TBL] [Abstract][Full Text] [Related]
36. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. Yamaguchi T; Hempson SJ; Reif GA; Hedge AM; Wallace DP J Am Soc Nephrol; 2006 Jan; 17(1):178-87. PubMed ID: 16319189 [TBL] [Abstract][Full Text] [Related]
37. Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 Tesla scanner. Sadick M; Schock D; Kraenzlin B; Gretz N; Schoenberg SO; Michaely HJ Invest Radiol; 2009 Aug; 44(8):469-75. PubMed ID: 19465861 [TBL] [Abstract][Full Text] [Related]
38. Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice. Woo DD; Nguyen DK; Khatibi N; Olsen P J Clin Invest; 1997 Oct; 100(8):1934-40. PubMed ID: 9329956 [TBL] [Abstract][Full Text] [Related]
39. In vitro fluid secretion by epithelium from polycystic kidneys. Grantham JJ; Ye M; Gattone VH; Sullivan LP J Clin Invest; 1995 Jan; 95(1):195-202. PubMed ID: 7814614 [TBL] [Abstract][Full Text] [Related]
40. Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. Mangoo-Karim R; Uchic ME; Grant M; Shumate WA; Calvet JP; Park CH; Grantham JJ FASEB J; 1989 Dec; 3(14):2629-32. PubMed ID: 2480260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]